SANUWAVE Health, Inc. (SNWV)

NASDAQ: SNWV · Real-Time Price · USD
7.63
-0.94 (-10.97%)
Jun 25, 2026, 4:00 PM EDT - Market closed
Market Cap65.61M -74.6%
Revenue (ttm)44.34M +22.5%
Net Income16.49M
EPS0.92
Shares Out 8.60M
PE Ratio8.27
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume201,985
Open8.61
Previous Close8.57
Day's Range7.53 - 8.68
52-Week Range7.53 - 46.59
Beta1.34
Analystsn/a
Price Targetn/a
Earnings DateMay 12, 2026

About SNWV

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and ch... [Read more]

Sector Healthcare
Founded 2004
Employees 55
Stock Exchange NASDAQ
Ticker Symbol SNWV
Full Company Profile

Financial Performance

Financial Statements

News

SANUWAVE Health Transcript: Planet MicroCap Las Vegas 2026

Wound care is undergoing a payer-driven shift to evidence-based medicine, creating opportunities for high-efficacy, cost-effective solutions. UltraMIST’s strong clinical evidence, expanding reimbursement, and consumables-driven model position it for growth, especially as it targets large enterprise accounts.

8 days ago - Transcripts

Sanuwave Health Updates Second Quarter 2026 Guidance

Sanuwave updates guidance for Q2 2026 to $8.5 - $9.5 million Company on pace for record unit sales of applicators in Q2 Market disruption impacting Ultramist system sales EDEN PRAIRIE, Minn., June 16,...

9 days ago - GlobeNewsWire

SANUWAVE Health Slides: Investor presentation

SANUWAVE Health has posted slides in relation to its latest quarterly earnings report, which was published on June 16, 2026.

9 days ago - Filings

SANUWAVE Health Transcript: AGM 2026

The meeting covered director elections, auditor ratification, and executive compensation votes. Quorum was met, voting was conducted online, and results will be disclosed in a Form 8-K. Only meeting-related questions were addressed during the Q&A.

14 days ago - Transcripts

SANUWAVE Health Earnings Call Transcript: Q1 2026

Record Q1 revenue and strong consumables growth were achieved despite a market freeze from CMS pricing changes. Guidance for 2026 remains robust, with expectations for a stronger second half driven by seasonality and large account engagement.

6 weeks ago - Transcripts

SANUWAVE Health Quarterly report: Q1 2026

SANUWAVE Health has published its Q1 2026 quarterly earnings report on May 13, 2026.

6 weeks ago - Filings

SANUWAVE Health Earnings release: Q1 2026

SANUWAVE Health released its Q1 2026 earnings on May 13, 2026, summarizing the period's financial results.

6 weeks ago - Filings

SANUWAVE Health Slides: Q1 2026

SANUWAVE Health has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 13, 2026.

6 weeks ago - Filings

Sanuwave Health reports Q1 EPS (17c) vs (72c) last year

Reports Q1 revenue $9.6M vs $9.3M last year. “The seemingly ubiquitous question in advanced wound care during Q1 was ‘When is the turn coming and when will the recovery start?’”…

6 weeks ago - TheFly

Sanuwave Health sees Q2 revenue $11.1M-$11.6M, one estimate $11.5M

17:03 EDT Sanuwave Health (SNWV) sees Q2 revenue $11.1M-$11.6M, one estimate $11.5M

6 weeks ago - TheFly

Sanuwave Health backs FY26 revenue view $51M-$55M, one estimate $51.35M

17:03 EDT Sanuwave Health (SNWV) backs FY26 revenue view $51M-$55M, one estimate $51.35M

6 weeks ago - TheFly

Sanuwave Announces Revenues and Financial Results for Q1 FY2026

Q1 2026 revenues were  $9.6 million , up 3.1% from $9.3 million in Q1 2025. This represents the highest Q1 quarterly revenues in Company history.

6 weeks ago - GlobeNewsWire

Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results

EDEN PRAIRIE, Minn., May 06, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will h...

7 weeks ago - GlobeNewsWire

SANUWAVE Health Proxy statement: Proxy filing

SANUWAVE Health filed a proxy statement on April 29, 2026, providing details for shareholder voting and corporate governance matters.

2 months ago - Filings

SANUWAVE Health Proxy statement: Proxy filing

SANUWAVE Health filed a proxy statement on April 29, 2026, providing details for shareholder voting and corporate governance matters.

2 months ago - Filings

Sanuwave Health narrows Q1 revenue view to $9.6M-$9.7M from $9.6M-$10.3M

Q1 revenue consensus $9.84M. “At the end of Q1 the Company saw several good-sized deals (all of which remain live) slide out of the quarter and this brought us in…

2 months ago - TheFly

Sanuwave Health price target lowered to $47 from $53 at Roth Capital

Roth Capital analyst Kyle Bauser lowered the firm’s price target on Sanuwave Health (SNWV) to $47 from $53 and keeps a Buy rating on the shares. Despite an FY26 revenue…

3 months ago - TheFly

SANUWAVE Health Earnings Call Transcript: Q4 2025

Record Q4 and full-year revenue growth driven by UltraMIST system sales and consumables, despite industry disruption from CMS reimbursement changes. Strategic channel shift to resellers and strong cash position support 2026 growth outlook of 16%–25%.

3 months ago - Transcripts

SANUWAVE Health Earnings release: Q4 2025

SANUWAVE Health released its Q4 2025 earnings on March 27, 2026, summarizing the period's financial results.

3 months ago - Filings

SANUWAVE Health Annual report: Q4 2025

SANUWAVE Health has published its Q4 2025 annual report on March 27, 2026.

3 months ago - Filings

SANUWAVE Health Slides: Q4 2025

SANUWAVE Health has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 27, 2026.

3 months ago - Filings

Sanuwave Health reports Q4 adjusted EBITDA $4.77M vs $3.66M last year

Reports Q4 revenue $13.4M, up 29.7% year-over-year. “We’re pleased to be, once more, announcing an all-time record quarter for Sanuwave on both revenues and adjusted EBITDA, especially during such cha...

3 months ago - TheFly

Sanuwave Health sees Q1 revenue $9.6M-$10.3M

17:02 EDT Sanuwave Health (SNWV) sees Q1 revenue $9.6M-$10.3M

3 months ago - TheFly

Sanuwave Health sees FY26 revenue $51M-$55M

17:03 EDT Sanuwave Health (SNWV) sees FY26 revenue $51M-$55M

3 months ago - TheFly

Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025

Q4 2025 revenues were  $13.4 million , up 29.7% from Q4 2024. This was an all-time quarterly record for the Company.

3 months ago - GlobeNewsWire